Document ZJ2aOaNYZ7z8GwMrmEXjJVeNY

BACK TO MAIN 3M FLUOROCHEMICAL SUBMISSION TOXICOLOGY, EPIDEMIOLOGY AND MEDICAL SURVEILLANCE October 1987-October 2005 Click on Study Title to View Report POSF Perfluorooctanesulfonyl fluoride 1. POSF 5-day Inhalation Toxicity Study a. Final Report, "Perfluorooctanesulfonyl Fluoride (POSF; T-7661.1) Preliminary Toxicity Study by Inhalation Administration to CD Rats for 1 Week," Huntingdon Life Sciences Ltd., Study No. MIN 312/014272, October 7, 2005. 2. POSF 90-day Inhalation Toxicity Study: a. Final Report, "Perfluorooctanesulfonyl Fluoride (POSF; T-7661.1) Toxicity Study by Inhalation Administration to CD Rats for 13 Weeks Followed by a 4 Week Recovery Period, Volume 1," Huntingdon Life Sciences Ltd., Study No. MIN 313/023622, September 28, 2005. b. Final Report, "Perfluorooctanesulfonyl Fluoride (POSF; T-7661.1) Toxicity Study by Inhalation Administration to CD Rats for 13 Weeks Followed by a 4 Week Recovery Period, Volume 2," Huntingdon Life Sciences Ltd., Study No. MIN 313/023622, September 28, 2005. c. Review letter by Samuel M. Cohen, M.D., Ph.D., University of Nebraska Medical Center, June 18, 2004. 3. "Bladder cancer in Perfluorooctanesulfonyl Fluoride Manufacturing Workers," Bruce H. Alexander (University of Minnesota), November 21, 2004.